Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NAD(P)H + 2,6-dichlorophenolindophenol
NAD(P)+ + reduced 2,6-dichlorophenolindophenol
-
-
-
?
NAD(P)H + K4Fe(CN)6
NAD(P)+ + K3Fe(CN)6
-
-
-
?
NADH + 2'-NADP+
NAD+ + 2'-NADPH
-
-
-
?
NADH + 3'-NADP+
NAD+ + 3'-NADPH
-
-
-
?
NADH + NADP+
NADPH + NAD+
-
-
-
?
NADH + thio-NAD+
NAD+ + thio-NADH
-
-
-
?
NADH + thio-NADP+
NAD+ + thio-NADPH
NADP+ + NADH
NADPH + NAD+
NADPH + 3-acetylpyridine-NAD+
NADP+ + 3-acetylpyridine-NADH
NADPH + deamino-NAD+
NADP+ + deamino-NADH
NADPH + NAD+
NADP+ + NADH
NADPH + pyridine aldehyde-NAD+
NADP+ + pyridine aldehyde-NADH
NADPH + thio-NAD+ + H+[side 1]
NADP+ + thio-NADH + H+[side 2]
NADPH + thio-NADP+ + H+[side 1]
NADP+ + thio-NADPH + H+[side 2]
NADH + thio-NADP+

NAD+ + thio-NADPH
-
-
-
?
NADH + thio-NADP+
NAD+ + thio-NADPH
-
-
-
-
r
NADH + thio-NADP+
NAD+ + thio-NADPH
-
-
-
-
r
NADP+ + NADH

NADPH + NAD+
Azotobacter agilis
-
degree of reversibility depends on source of enzyme
-
r
NADP+ + NADH
NADPH + NAD+
-
degree of reversibility depends on source of enzyme
-
r
NADP+ + NADH
NADPH + NAD+
-
-
-
?
NADP+ + NADH
NADPH + NAD+
-
-
-
r
NADP+ + NADH
NADPH + NAD+
-
diaphorase-type reactions with NAD(P)H, K3Fe(CN)6 and 2,6-dichlorophenol indophenol
-
?
NADP+ + NADH
NADPH + NAD+
Chromatium sp.
-
poorly reversible
-
-
r
NADP+ + NADH
NADPH + NAD+
-
-
-
-
r
NADP+ + NADH
NADPH + NAD+
-
-
-
-
r
NADP+ + NADH
NADPH + NAD+
-
4B-specific for NAD(P)H
-
-
?
NADP+ + NADH
NADPH + NAD+
-
-
-
r
NADP+ + NADH
NADPH + NAD+
-
4B-specific for NAD(P)H
-
?
NADP+ + NADH
NADPH + NAD+
-
reduction of NADP+ is preferred
-
r
NADP+ + NADH
NADPH + NAD+
-
diaphorase-type reactions with NAD(P)H, K3Fe(CN)6 and 2,6-dichlorophenol indophenol
-
?
NADP+ + NADH
NADPH + NAD+
-
-
-
-
?
NADP+ + NADH
NADPH + NAD+
-
degree of reversibility depends on source of enzyme
-
r
NADP+ + NADH
NADPH + NAD+
-
4B-specific for NAD(P)H
-
-
?
NADP+ + NADH
NADPH + NAD+
-
reduction of NADP+ is preferred
-
r
NADPH + 3-acetylpyridine-NAD+

NADP+ + 3-acetylpyridine-NADH
-
-
-
?
NADPH + 3-acetylpyridine-NAD+
NADP+ + 3-acetylpyridine-NADH
-
-
-
?
NADPH + 3-acetylpyridine-NAD+
NADP+ + 3-acetylpyridine-NADH
-
-
-
?
NADPH + deamino-NAD+

NADP+ + deamino-NADH
-
-
-
?
NADPH + deamino-NAD+
NADP+ + deamino-NADH
-
-
-
?
NADPH + deamino-NAD+
NADP+ + deamino-NADH
-
-
-
?
NADPH + deamino-NAD+
NADP+ + deamino-NADH
-
-
-
?
NADPH + deamino-NAD+
NADP+ + deamino-NADH
-
-
-
?
NADPH + NAD+

NADP+ + NADH
-
-
-
-
?
NADPH + NAD+
NADP+ + NADH
-
-
-
?
NADPH + NAD+
NADP+ + NADH
-
-
-
r
NADPH + NAD+
NADP+ + NADH
-
-
-
-
?
NADPH + NAD+
NADP+ + NADH
-
-
-
-
?
NADPH + pyridine aldehyde-NAD+

NADP+ + pyridine aldehyde-NADH
-
-
-
?
NADPH + pyridine aldehyde-NAD+
NADP+ + pyridine aldehyde-NADH
-
-
-
?
NADPH + pyridine aldehyde-NAD+
NADP+ + pyridine aldehyde-NADH
-
-
-
?
NADPH + thio-NAD+ + H+[side 1]

NADP+ + thio-NADH + H+[side 2]
-
-
-
?
NADPH + thio-NAD+ + H+[side 1]
NADP+ + thio-NADH + H+[side 2]
-
-
-
r
NADPH + thio-NAD+ + H+[side 1]
NADP+ + thio-NADH + H+[side 2]
EcSTH has a 1.25fold preference for NADPH over thio-NAD+
-
-
r
NADPH + thio-NADP+ + H+[side 1]

NADP+ + thio-NADPH + H+[side 2]
-
-
-
?
NADPH + thio-NADP+ + H+[side 1]
NADP+ + thio-NADPH + H+[side 2]
-
-
-
?
NADPH + thio-NADP+ + H+[side 1]
NADP+ + thio-NADPH + H+[side 2]
-
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5'-AMP
-
5 mM, 92% inhibition of NADP+ reduction, complete inhibition of NAD+ reduction
ADP
-
5 mM, 94% inhibition of NADP+ reduction, complete inhibition of NAD+ reduction
arsenate
-
complete inhibition of activity in either direction
ATP
-
5 mM, 81% inhibition of NADP+ reduction, complete inhibition of NAD+ reduction
beta-mercaptoethanol
72% residual activity at 0.2% (v/v)
Ca2+
91.2% residual activity at 2 mM; slightly inhibitory
CTP
-
5 mM, 86% inhibition of NADP+ reduction
Cu2+
complete inhibition at 2 mM
diphosphate
-
5 mM, 91% inhibition of NADP+ reduction
dithiothreitol
75.3% residual activity at 2 mM
EDTA
72.6% residual activity at 2 mM
GTP
-
5 mM, 89% inhibition of NADP+ reduction
Mn2+
67% residual activity at 2 mM
NAD+
-
competitive to thio-NAD+, uncompetitive with respect to NADPH
NADPH
EcSTH activity is strongly inhibited by excess NADPH, but not by thio-NAD+; the enzyme is strongly inhibited by excess NADPH
Ni2+
7.4% residual activity at 2 mM
p-Aminophenylarsenoxide
-
0.1 mM, 40-60% inhibition in the absence of either phosphate or magnesium ions, reduction of NAD+ by NADPH in cell-free extracts is rapidly and completely inhibited in the presence of 20 mM phosphate
p-chloromercuribenzoate
-
0.044 mM, 40-50% inhibition after 30 min, activity can be restored by adding 2-mercaptoethanol
phosphoenolpyruvate
-
87% inhibition of NADP+ reduction
pyridoxal 5'-phosphate
-
5 mM, 91% inhibition of NADP+ reduction
TTP
-
2 mM, 71% inhibition of NADP+ reduction
Zn2+
10.1% residual activity at 2 mM
2'-AMP

Chromatium sp.
-
-
NADP+

-
uncompetitive to thio-NAD+
NADP+
-
0.01 mM, 28% inhibition of NAD+ reduction with NADPH, 12.5% inhibition of NADP+ reduction with NADPH; inhibition of 2'-AMP activated reaction
NADP+
-
inhibition in absence of Ca2+; strong inhibition in the absence of Ca2+, saturation with Ca2+ completely abolishes inhibition
p-hydroxymercuribenzoate

-
-
p-hydroxymercuribenzoate
-
-
p-hydroxymercuribenzoate
-
dependent on presence of oxidized or reduced substrate
phosphate

-
10-25 mM, 60-70% inhibition of purified enzyme, complete inhibition of enzyme in cell-free extracts by 5-10 mM phosphate, NADP+ reduction by NADH is inhibited, reduction of NAD+ by NADPH is hardly affected
phosphate
-
5 mM, complete inhibition of activity in either direction
additional information

-
no or poor inhibition of the enzyme by Na+, Rb+, K+, Li+,, and Mg2+; the enzyme is not inhibited by thio-NAD+ and DMSO
-
additional information
no or poor inhibition of the enzyme by Na+, Rb+, K+, Li+,, and Mg2+; the enzyme is not inhibited by thio-NAD+ and DMSO
-
additional information
-
not inhibited by palmitoyl-CoA, not affected by treatment with 0.2 mg trypsin/mg protein
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenoma
Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt.
Adrenal Insufficiency
Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model.
Adrenal Rest Tumor
Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency.
Adrenocortical Carcinoma
Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma.
Atherosclerosis
Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
Bacteremia
Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection.
Breast Neoplasms
Transcription Levels of nicotinamide nucleotide transhydrogenase and Its Antisense in Breast Cancer Samples.
Carcinoma
NNT in NSCLC: No need to worry?
Carcinoma, Hepatocellular
Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Pyridine-adenine dinucleotide transhydrogenase activity in cells cultured from rat hepatoma.
Carcinoma, Non-Small-Cell Lung
LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Carcinoma, Non-Small-Cell Lung
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function.
Carcinoma, Non-Small-Cell Lung
NNT in NSCLC: No need to worry?
Cardiomyopathies
Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not.
Cystinosis
Enzymic reduction of cystine and glutathione in cultivated human fibroblast from normal subjects and patients with cystinosis.
Diabetes Mellitus, Type 1
Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model.
Glucose Intolerance
A High-Throughput Assay for Modulators of NNT Activity in Permeabilized Yeast Cells.
Glucose Intolerance
Defective insulin secretory response to intravenous glucose in C57Bl/6J compared to C57Bl/6N mice.
Glucose Intolerance
Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice.
Glucose Intolerance
Dysregulation of glucose homeostasis in nicotinamide nucleotide transhydrogenase knockout mice is independent of uncoupling protein 2.
Glucose Intolerance
K(ATP) channels and insulin secretion: a key role in health and disease.
Glucose Intolerance
Mitochondrial transhydrogenase--a key enzyme in insulin secretion and, potentially, diabetes.
Glucose Intolerance
Nicotinamide nucleotide transhydrogenase mRNA expression is related to human obesity.
Glucose Intolerance
Obesity and Type 2 Diabetes: Slow Down! - Can Metabolic Deceleration Protect The Islet Beta Cell From Excess Nutrient-Induced Damage?
Heart Failure
Mitochondrial Bioenergetics and Dysfunction in Failing Heart.
Hypertension
Nicotinamide nucleotide transhydrogenase activity impacts mitochondrial redox balance and the development of hypertension in mice.
Hypothyroidism
Nicotinamide nucleotide transhydrogenase mutation analysis in Chinese patients with thyroid dysgenesis.
Infections
Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection.
Liver Neoplasms, Experimental
Comparison of transhydrogenase and pyridine nucleotide-cytochrome c reductase activities in rat liver and Novikoff hepatoma.
Lung Neoplasms
LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Lung Neoplasms
LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Lung Neoplasms
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function.
Malaria
NAD(P) transhydrogenase has vital non-mitochondrial functions in malaria parasite transmission.
Metabolic Diseases
A Direct Comparison of Metabolic Responses to High Fat Diet in C57BL/6J and C57BL/6NJ Mice.
Multiple Sclerosis
Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.
nad(p)+ transhydrogenase (si-specific) deficiency
Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency.
nad(p)h oxidase (h2o2-forming) deficiency
Downregulation of DUOX1 function contributes to aging-related impairment of innate airway injury responses and accelerated senile emphysema.
Neoplasms
Combined adrenal failure and testicular adrenal rest tumor in a patient with nicotinamide nucleotide transhydrogenase deficiency.
Neoplasms
Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma.
Neoplasms
Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.
Neoplasms
Mammalian NADH:ubiquinone oxidoreductase (Complex I) and nicotinamide nucleotide transhydrogenase (Nnt) together regulate the mitochondrial production of H?O?--implications for their role in disease, especially cancer.
Neoplasms
Nicotinamide nucleotide transhydrogenase acts as a new prognosis biomarker in hepatocellular carcinoma.
Neoplasms
NNT-induced tumor cell "slimming" reverses the pro-carcinogenesis effect of HIF2a in tumors.
Neoplasms
Serum long non?coding RNA NNT?AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR?496/RAP2C axis in colorectal cancer.
Neoplasms
Studies on the isocitrate dehydrogenase. II. Isocitrate dehydrogenase and transhydrogenase in tumor bearing rat liver and ascites tumor cells.
Neoplasms
Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Neoplasms
[Occurrence of pyridine nucleotide transhydrogenase in mitochondria of various ascites tumors]
Obesity
Adipose tissue metabolism and inflammation are differently affected by weight loss in obese mice due to either a high-fat diet restriction or change to a low-fat diet.
Obesity
Alterations of Pancreatic Islet Structure, Metabolism and Gene Expression in Diet-Induced Obese C57BL/6J Mice.
Obesity
Diet-induced Obesity in Two C57BL/6 Substrains With Intact or Mutant Nicotinamide Nucleotide Transhydrogenase (Nnt) Gene.
Obesity
Nicotinamide Nucleotide Transhydrogenase (Nnt) is Related to Obesity in Mice.
Obesity
Nicotinamide nucleotide transhydrogenase mRNA expression is related to human obesity.
Obesity
Obesity and Type 2 Diabetes: Slow Down! - Can Metabolic Deceleration Protect The Islet Beta Cell From Excess Nutrient-Induced Damage?
Osteosarcoma
Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Pneumonia
Evidence for a nicotinamide nucleotide transhydrogenase in Klebsiella pneumoniae.
Stomach Neoplasms
Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer.
Stomach Neoplasms
Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer.
Thyroid Cancer, Papillary
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Thyroid Dysgenesis
Nicotinamide nucleotide transhydrogenase mutation analysis in Chinese patients with thyroid dysgenesis.
Tics
Upregulation of mitochondrial NAD(+) levels impairs the clonogenicity of SSEA1(+) glioblastoma tumor-initiating cells.
Tuberculosis
A hybrid of the transhydrogenases from Rhodospirillum rubrum and Mycobacterium tuberculosis catalyses rapid hydride transfer but not the complete, proton-translocating reaction.
Tuberculosis
Isolation of a 43 kDa protein from Mycobacterium tuberculosis H37Rv and its identification as a pyridine nucleotide transhydrogenase.
Tuberculosis
Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies.
Tuberculosis
Similarities between alanine dehydrogenase and the N-terminal part of pyridine nucleotide transhydrogenase and their possible implication in the virulence mechanism of Mycobacterium tuberculosis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.